At close: 4:08:20 PM GMT+8
Breakdown
12/31/2023
12/31/2022
12/31/2021
Total Assets
874,590.000
839,978.000
892,835.000
Total Liabilities Net Minority Interest
126,303.000
60,757.000
2,491,274.000
Total Equity Gross Minority Interest
748,287.000
779,221.000
-1,598,439.000
Total Capitalization
748,287.000
779,221.000
-1,598,439.000
Common Stock Equity
748,287.000
779,221.000
-1,598,439.000
Capital Lease Obligations
14,793.000
14,619.000
18,539.000
Net Tangible Assets
672,542.000
699,248.000
-1,682,640.000
Working Capital
570,792.000
600,134.000
-1,773,733.000
Invested Capital
808,267.000
779,221.000
-1,598,439.000
Tangible Book Value
672,542.000
699,248.000
-1,682,640.000
Total Debt
74,773.000
14,619.000
18,539.000
Share Issued
374,157.695
373,239.895
373,239.895
Ordinary Shares Number
374,157.695
373,239.895
373,239.895
12/31/2021 - 9/5/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
9969.HK InnoCare Pharma Limited
6.150
-0.32%
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
179.400
-4.37%
688266.SS Suzhou Zelgen Biopharmaceuticals Co.,Ltd.
64.64
-4.36%
2105.HK Laekna, Inc.
10.840
-8.75%
688428.SS InnoCare Pharma Limited
13.39
-1.76%
2487.HK Cutia Therapeutics
7.010
-1.27%
3681.HK SinoMab BioScience Limited
1.050
-5.41%
9966.HK Alphamab Oncology
3.410
-7.59%
2162.HK Keymed Biosciences Inc.
34.550
-8.84%
6628.HK Transcenta Holding Limited
0.610
0.00%